ecqm.unions

Low Riskfor Vt Eor Anticoagulant Administered Union

Description:

Based On: Union70

Used By:

• CMS108v7,
• CMS190v7

QDM Attributes

InrPerformed

Clinical Focus: This set of values contains codes for laboratory test for INR, or International Normalized Ratio.

Data Element Scope: The intent of this data element is to identify INR laboratory tests. Using the Quality Data Model, this data element maps to the Laboratory Test category.

Inclusion Criteria: Only include codes which represent a laboratory test of INR (International Normalized Ratio). These are LOINC codes.

Exclusion Criteria: None

Subject constrained to the INR

LaboratoryTestPerformed: Data elements that meet criteria using this datatype should document the laboratory test indicated by the QDM category and its corresponding value set was performed. Timing: The Relevant Period addresses: startTime – When the laboratory test is initiated (i.e., the time the specimen collection begins). stopTime – when the laboratory test is completed (i.e., the time the specimen collection ends). Examples: 1) Initiation of a venipuncture for a fasting blood glucose to the time venipuncture for the fasting blood glucose is completed – basically a single point in time for many specimen collections. 2) Initiation of a 24-hour urine collection for measured creatinine clearance until completion of the 24-hour urine collection Note – the time that the result report is available is a separate attribute than the time of the study (specimen collection)

DataType

Cardinality

InrPerformed

0..*

UnfractionatedHeparinAdministered

Clinical Focus: This value set identifies heparin formulations that could reasonably be used to treat venous thromboembolism as a continuous infusion.

Data Element Scope: The intent of this data element is to identify patients who receive unfractionated heparin as an intravenous infusion. Using the Quality Data Model, this particular element will map to the Medication category.

Inclusion Criteria: Injectable products that could reasonably be used for continuous infusion of heparin and achieve therapeutic levels.

Exclusion Criteria: Concentrations < 250 UNT/ML (except those representing premixed heparin infusion bags, per inclusion criteria

Subject constrained to the Unfractionated Heparin

MedicationAdministered: Data elements that meet criteria using this datatype should document that the medication indicated by the QDM category and its corresponding value set was actually administered to the patient. Timing: The Relevant Period addresses: startTime = when a single medication administration event starts (e.g., the initiation of an intravenous infusion, or administering a pill or IM injection to a patient); stopTime = when a single medication administration event ends (e.g., the end time of the intravenous infusion, or the administration of a pill or IM injection is completed - for pills and IM injections, the start and stop times are the same) NOTE – Measure developers should address multiple administrations over a period of time using CQL logic. Refer to Special Cases in Appendix A (Section A.3) for scenarios to consider in calculating cumulative medication duration.

DataType

Cardinality

UnfractionatedHeparinAdministered

0..*

DirectThrombinInhibitorAdministered

Clinical Focus: This set of values contains codes which identify a select medication-a direct thrombin inhibitor.

Data Element Scope: The intent of this data element is to identify patients who are on a direct thrombin inhibitor. Using the Quality Data Model, this data element maps to the Medication category.

Inclusion Criteria: Only include codes which represent direct thrombin inhibitors. These are RxNorm codes.

Exclusion Criteria: None

Subject constrained to the Direct Thrombin Inhibitor

MedicationAdministered: Data elements that meet criteria using this datatype should document that the medication indicated by the QDM category and its corresponding value set was actually administered to the patient. Timing: The Relevant Period addresses: startTime = when a single medication administration event starts (e.g., the initiation of an intravenous infusion, or administering a pill or IM injection to a patient); stopTime = when a single medication administration event ends (e.g., the end time of the intravenous infusion, or the administration of a pill or IM injection is completed - for pills and IM injections, the start and stop times are the same) NOTE – Measure developers should address multiple administrations over a period of time using CQL logic. Refer to Special Cases in Appendix A (Section A.3) for scenarios to consider in calculating cumulative medication duration.

DataType

Cardinality

DirectThrombinInhibitorAdministered

0..*

GlycoproteinIIbIiIaInhibitorsAdministered

Clinical Focus: This set of values contains codes which identify a select medication-a Glycoprotein Iib/IIIa inhibitor.

Data Element Scope: The intent of this data element is to identify patients who are on a Glycoprotein Iib/IIIa inhibitor. Using the Quality Data Model, this data element maps to the Medication category.

Inclusion Criteria: Only include codes which represent a Glycoprotein Iib/IIIa inhibitor. These are RxNorm codes.

Exclusion Criteria: None

Subject constrained to the Glycoprotein IIb/IIIa Inhibitors

MedicationAdministered: Data elements that meet criteria using this datatype should document that the medication indicated by the QDM category and its corresponding value set was actually administered to the patient. Timing: The Relevant Period addresses: startTime = when a single medication administration event starts (e.g., the initiation of an intravenous infusion, or administering a pill or IM injection to a patient); stopTime = when a single medication administration event ends (e.g., the end time of the intravenous infusion, or the administration of a pill or IM injection is completed - for pills and IM injections, the start and stop times are the same) NOTE – Measure developers should address multiple administrations over a period of time using CQL logic. Refer to Special Cases in Appendix A (Section A.3) for scenarios to consider in calculating cumulative medication duration.

DataType

Cardinality

GlycoproteinIIbIiIaInhibitorsAdministered

0..*